Immunic, Inc. (IMUX) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Immunic, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.796 -- 00:00:05.578 Good morning and welcome to Munich's second quarter 2024 earnings call. 00:00:05.578 -- 00:00:10.199 My name is Jessica Brue, Vice President, Investor Relations and Communications at eMunich. 00:00:10.199 -- 00:00:13.960 I will also be the moderator today. Speaking on the call are Dr. 00:00:13.960 -- 00:00:18.822 Daniel Fitt, our Chief Executive Officer, Glenn Whaley, our Chief Financial Officer, 00:00:18.822 -- 00:00:23.623 as well as Jason Tardio, our newly appointed Chief Operating Officer and President. 00:00:23.623 -- 00:00:27.325 Please note that all participants will be in listen-only mode and this event is being 00:00:27.325 -- 00:00:28.951 recorded. 00:00:28.951 -- 00:00:33.013 After today's presentation, there will be an opportunity to ask questions. 00:00:33.013 -- 00:00:37.335 If you joined the webcast via the Zoom platform, there are two ways to submit questions. 00:00:37.335 -- 00:00:41.537 You can either submit your questions in writing via the Q&A tool of the Zoom portal, 00:00:41.537 -- 00:00:45.479 or if you would like to speak with us directly, please use the raise hand function in 00:00:45.479 -- 00:00:48.141 the Zoom portal to queue your question. 00:00:48.141 -- 00:00:52.623 Before we begin, I would like to remind you that this presentation may contain forward-looking 00:00:52.623 -- 00:00:58.128 statements. Such statements can be identified by words such as may, will, 00:00:58.128 -- 00:01:02.049 expect, anticipate, estimate, or words with a similar meaning. 00:01:02.049 -- 00:01:06.631 And such statements involve a number of risks and uncertainties that could cause Immunix's 00:01:06.631 -- 00:01:10.352 actual results to differ materially from those discussed here. 00:01:10.352 -- 00:01:14.893 Please note th...